Skip to content

OncoHost vs Peptomyc

OncoHost logo

OncoHost

A technology company transforming the approach to precision medicine for improved patient outcomes

53 employees · est. 2017 · Binyamina, Israel

VS
Peptomyc logo

Peptomyc

Developing Peptides to treat Cancer

23 employees · est. 2014 · Barcelona, Spain

Peptomyc is the older company (2017 vs 2014); OncoHost is the larger of the two.

Side-by-Side Comparison

OncoHost Peptomyc
Founded
2017 2014 older
Headquarters
Binyamina, Israel Barcelona, Spain
Employees
53 larger 23
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Series C Not tracked yet
Total Funding
$52.56M $49.47M
Funding Rounds
4 13
Services
Not tracked yet Development of MYC inhibitory drugs, Clinical trial management, Biotechnological research and innovation
Target Customers
Not tracked yet Cancer patients with abnormal MYC activity, Healthcare providers, Oncology research institutions, Pharmaceutical partners
Taxonomy
Precision MedicineTechnology CompanyPROphet® PlatformProteomic Pattern AnalysisNon-small Cell Lung Cancer (NSCLC)Immunotherapy Decision-making +9 Cell Penetrating PeptidesMyc OncoproteinCancer TreatmentOmomycDrug DevelopmentOncology +8
Website
oncohost.com peptomyc.com
OncoHost logo

About OncoHost

OncoHost is a technology company based in Israel that is revolutionizing the field of precision medicine to enhance patient outcomes. The company's flagship product, PROphet®, utilizes a plasma-based, proteomic pattern analysis to deliver personalized treatment insights for non-small cell lung cance...

Peptomyc logo

About Peptomyc

Peptomyc, with its slogan "Developing Peptides to treat Cancer", is prominently positioned at the intersection of Biotechnology and Health Care. Founded in 2014, this Spain-based company is pioneering a new class of cell-penetrating peptides (CPPs) aimed at targeting the notorious Myc oncoprotein, a...

Also comparing in this category

Comparing more than these two?

Get OncoHost, Peptomyc and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does OncoHost compare?

A PDF of OncoHost and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

OncoHost was founded in 2017, based in Binyamina, Israel, with 53 employees. OncoHost is a technology company based in Israel that is revolutionizing the field of precision medicine to enhance patient outcomes. The company's flagship product, PROphet®, utilizes a plasma-based,. Peptomyc was founded in 2014, based in Barcelona, Spain, with 23 employees. Peptomyc, with its slogan "Developing Peptides to treat Cancer", is prominently positioned at the intersection of Biotechnology and Health Care. Founded in 2014, this Spain-based company is pioneering.
OncoHost has raised $52.56M and Peptomyc $49.47M. Latest stage: OncoHost Series C.
Both work in Biotechnology and Health Care and list precision medicine, non-small cell lung cancer (nsclc) and oncology among their focus areas.

Compare OncoHost with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at OncoHost on 12 Sep 2024, and Peptomyc on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout